Quince Therapeutics to host virtual KOL event on Sept. 28
Quince Therapeutics (NASDAQ: QNCX) announced it will host a virtual KOL event on September 28, 2026 to discuss the treatment landscape for PH-ILD and BOS and the role for LAM-001 as a potential therapeutic option.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.